Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

74 Parkinson’s Trials Are Not Yet Recruiting

Trial Name Last Updated
Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study 01/09/2019
Precision Medical Diagnosis and Acupuncture Treatment for Parkinson's Disease 01/03/2019
Biomarker Assessments of Leukine During Treatment of Parkinson's Disease 01/01/2019
Left Atrial Appendage Closure in Combination With Catheter Ablation 12/28/2018
Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease 12/20/2018
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) 12/19/2018
The Effect of Whole Body Vibration in Individuals With Parkinson's Disease 12/17/2018
Optimization of VIM Targeting in Essential Tremor Surgery 11/30/2018
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) 11/28/2018
A Phase 2 Study of K0706 for Early Parkinson's Disease 11/28/2018
Spine MRI in DBS Patients 11/27/2018
Immersive Virtual Reality to Improve Gait in Parkinson's Disease 11/06/2018
rTMS Treatment in Vascular Parkinsonism 10/30/2018
Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD 10/26/2018
Movement Disorders and Early Maladaptive Schemas 10/24/2018
Comparing the Effects of Instability Resistance Training Versus Aerobic Training on Cognitive and Motor Improvements Found in Parkinson's Disease Participants 10/19/2018
Gut Microbiota and Parkinson's Disease 10/18/2018
Reducing Disparities in the Quality of Advance Care Planning for Older Adults 10/18/2018
Study of the Fecal Microbiome in Patients With Parkinson's Disease 09/28/2018
A Study to Evaluate in Patients With Parkinsonian Type Disorders 09/25/2018
Study of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls. 09/24/2018
Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD 09/20/2018

Page 1 of 4 pages  1 2 3 >  Last ›

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).